These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 13674332)

  • 1. Spiramycin; clinical evaluation in infections due to gram-positive organisms.
    BERRY JW
    Mo Med; 1959 Aug; 56(8):905-7. PubMed ID: 13674332
    [No Abstract]   [Full Text] [Related]  

  • 2. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.
    Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD
    J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of the antibiotic association oxytetracycline-oleandomycin in the treatment of various infections in medical and surgical practice].
    SAAVEDRA AMARO S; LOPEZ ZEPEDA L
    Medicina (Mex); 1958 Dec; 38(809):552-6. PubMed ID: 13621976
    [No Abstract]   [Full Text] [Related]  

  • 4. Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms.
    Garrison MW; Neumiller JJ; Setter SM
    Clin Ther; 2005 Jan; 27(1):12-22. PubMed ID: 15763603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotics; their clinical use in the management of infections.
    BENNETT IL
    Conn State Med J; 1954 Nov; 18(11):879-90. PubMed ID: 13209974
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacologic options for CNS infections caused by resistant Gram-positive organisms.
    Peppard WJ; Johnston CJ; Urmanski AM
    Expert Rev Anti Infect Ther; 2008 Feb; 6(1):83-99. PubMed ID: 18251666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlamydia pneumoniae infection in patients after kidney transplantation treated with spiramycin.
    Fesolowicz S; Kwiatkowski A; Wszola M; Podsiadly E; Ostrowski K; Durlik M; Paczek L; Tylewska-Wierzbanowska S; Rowinski W; Chmura A
    Transplant Proc; 2009; 41(1):167-9. PubMed ID: 19249505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical verification of sigmamycin in the treatment of various infections.
    SAAVEDRA AMARO S; LOPEZ ZEPEDA L
    Medicina (Mex); 1958 Aug; 38(802):396-400. PubMed ID: 13589446
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of infections observed in clinical practice with oleandomycin-tetracycline.
    QUIRNO N; FUKELMAN R; DE ACHAVAL M
    Dia Med; 1958 Nov; 30(83):2938 passim. PubMed ID: 13609456
    [No Abstract]   [Full Text] [Related]  

  • 10. New antibiotic agents for bloodstream infections.
    Vergidis PI; Falagas ME
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S60-5. PubMed ID: 18723329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: dalbavancin--a novel lipoglycopeptide antimicrobial for gram positive pathogens.
    Das B; Sarkar C; Biswas R; Pandey S
    Pak J Pharm Sci; 2008 Jan; 21(1):78-87. PubMed ID: 18166524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pristinamycin as adjunctive therapy in the management of Gram-positive multi-drug resistant organism (MDRO) osteoarticular infection.
    Ruparelia N; Atkins BL; Hemingway J; Berendt AR; Byren I
    J Infect; 2008 Sep; 57(3):191-7. PubMed ID: 18703231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing antimicrobial therapy for gram-positive bloodstream infections in patients on hemodialysis.
    Pai AB; Pai MP
    Adv Chronic Kidney Dis; 2006 Jul; 13(3):259-70. PubMed ID: 16815231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in the treatment of infections caused by gram-positive and gram-negative bacteria in patients with cancer and neutropenia.
    Rolston KV
    Clin Infect Dis; 2005 Apr; 40 Suppl 4():S246-52. PubMed ID: 15768330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria.
    Stryjewski ME; O'Riordan WD; Lau WK; Pien FD; Dunbar LM; Vallee M; Fowler VG; Chu VH; Spencer E; Barriere SL; Kitt MM; Cabell CH; Corey GR;
    Clin Infect Dis; 2005 Jun; 40(11):1601-7. PubMed ID: 15889357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic concepts in the chemotherapy of bacterial infections.
    LIMSON BM
    Philipp J Surg; 1958; 13(2):168-80. PubMed ID: 13567009
    [No Abstract]   [Full Text] [Related]  

  • 18. Problems in the treatment of refractory bacterial infections.
    BRYER MS; SCHNEIERSON SS
    J Mt Sinai Hosp N Y; 1954; 20(5):285-92. PubMed ID: 13131052
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibiotics for gram-positive bacterial infections: vancomycin, quinupristin-dalfopristin, linezolid, and daptomycin.
    Lundstrom TS; Sobel JD
    Infect Dis Clin North Am; 2004 Sep; 18(3):651-68, x. PubMed ID: 15308280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Trial therapy of infections by the combination of antibiotics with a bacterial hydrolysate].
    RAVINA A
    Presse Med (1893); 1958 Nov; 66(84):1889. PubMed ID: 13623698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.